Manufacturing News of Note—Dr. Reddy's, Teva and more Thursday, November 21, 2019 Teva will produce its new migraine drug at a plant in Israel and more news of note.
Otsuka, China's bidding, Aurobindo and more—FiercePharmaAsia by Angus Liu Friday, September 27, 2019 Avanir pays $116 million in Neudexta kickback suits; China unveils results for a procurement scheme; Aurobindo founder faces insider trading fine.
Lantus copy, CStone CEO and Novartis plant—FiercePharmaAsia by Angus Liu Friday, September 6, 2019 Biocon's manufacturing problems cost it and Mylan again; CStone's CEO racks up nearly $20 million in 2018 pay; Novartis sells Suzhou plant.
Manufacturing News of Note—Olon, Hikma and WuXi STA Thursday, July 25, 2019 Here is some news of note for the week.
Takeda-Novartis, Daiichi-AZ and more—FiercePharmaAsia by Angus Liu Friday, May 10, 2019 Takeda sells meds to Novartis and J&J; Daiichi's AZ-shared HER2 antibody-drug conjugate hits key trial goal; Sun scouts for Chinese partner.
PD-1 royalty dispute, Takeda and more—FiercePharmaAsia by Angus Liu Friday, April 12, 2019 Nobel laureate wants bigger PD-1 revenue cut; Takeda scouts buyers for Latin America business; Chinese genomics investor is forced out of U.S. firm.
GSK-Bharat, Dr. Reddy's, Sandoz and more—FiercePharmaAsia by Angus Liu Friday, February 22, 2019 GSK sells Indian vaccine subsidiary to Bharat; Dr. Reddy's rides a turbulent week; Sandoz sells more U.S. generics.
Pfizer, Gilead-Yuhan and more—FiercePharmaAsia by Angus Liu Friday, January 11, 2019 Pfizer closes two Hospira plants in India; Gilead licenses Yuhan's NASH programs; Fujifilm is expanding its footprint in the U.S.
Genentech espionage, Astellas and more—FiercePharmaAsia by Angus Liu Friday, November 2, 2018 Ex-Roche scientists were charged with stealing trade secrets; Astellas invested in gene and cell therapy; Takeda touted growth in key focus areas.
HKEX, Zai Lab, WuXi and more—FiercePharmaAsia by Angus Liu Friday, August 31, 2018 Ascletis' stock price slips 44% in a month on HKEX; Zai Lab cans a dermatitis drug licensed from GSK; WuXi names CFO a co-CEO; and more.